Figure 3.
Results from overnight (12-h) urinary collections for conjugated sex steroids by diagnosis (C, daughter of control mother; P, PCOS mother), number of subjects per group (directly under the diagnosis), and percentage of detectable hormone and Tanner stage. No significant differences between groups in median levels (▪) by Tanner stage were noted.

Results from overnight (12-h) urinary collections for conjugated sex steroids by diagnosis (C, daughter of control mother; P, PCOS mother), number of subjects per group (directly under the diagnosis), and percentage of detectable hormone and Tanner stage. No significant differences between groups in median levels (▪) by Tanner stage were noted.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close